Tumor development, or tumorigenesis, broadly describes the process by which normal cells gain malignant properties. Tumor development includes growth functions like cellular differentiation, proliferation, and metastasis.
-
MAR 30, 2023 | 12:25 PM
C.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
Date: March 23, 2023 Time: 8:00am (PDT), 11:00am (EDT), 8:00pm (CEST) Across clinical oncology applications, from molecular testing to cancer research the ability to identify potentially act...
MAR 08, 2023 | 1:30 PM
C.E. CREDITS
Spatial mapping of pain-associated G-Protein coupled receptors and bio-marker localization in mouse brain using RNAscope HiPlex v2 and RNA-Protein Co-Detection Assays....
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...
FEB 08, 2023 | 9:00 AM
C.E. CREDITS
Date: February 08, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Understanding cell-to-cell interactions in a tumor microenvironment are increasingly challenging due to the complexit...
JAN 31, 2023 | 10:00 AM
C.E. CREDITS
Date: January 31, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Immunohistochemistry (IHC) is a standard technique for scientists and pathologists to detect antigens. Examining one o...
DEC 07, 2022 | 9:00 AM
C.E. CREDITS
Date: December 07, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Join us for an exciting live panel webinar, as we celebrate the 60th anniversary of Gibco Cell Culture. The panelists...
NOV 16, 2022 | 7:00 PM
C.E. CREDITS
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
Date: November 16, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) No more estimating. No more ranges. No more uncertainty. While PDX tumor models are crucial for gaining predictive ins...
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
Date: October 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Immunotherapy has transformed the treatment of metastatic and recurrent solid tumors. Advances in technology in the pa...
OCT 20, 2022 | 9:00 AM
C.E. CREDITS
Date: October 13, 2022 Time: 11:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Single-cell atlases mapping immune cells provide hints on how immune cells mature, attenuate, and disseminate through...
OCT 05, 2022 | 9:00 AM
C.E. CREDITS
Learning Objectives 1. Identify 3 obstacles that inhibit the immune cell response to cancer. 2. List 3 aspects of T cells antitumor function that can be improved with costimulatory signals....
The majority of disease-associated genetic variants are thought to have regulatory effects, including disruption of transcription factor (TF) binding and alteration of downstream gene expres...
Date: September 22, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Liquid biopsies are used to identify and track genetic mutationsin cancer patinets, enabling researchers to detect c...
SEP 21, 2022 | 6:00 AM
C.E. CREDITS
In the United States, prostate cancer (PCa) is the second-leading cause of cancer death in men. Multiple observations indicate the link between prostate carcinogenesis, stress of endoplasmi...